160 related articles for article (PubMed ID: 25267050)
1. Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis.
Sheppard JP; Fletcher K; McManus RJ; Mant J
Br J Gen Pract; 2014 Oct; 64(627):e641-8. PubMed ID: 25267050
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of hypertension therapy according to 2014 guidelines.
Moran AE; Odden MC; Thanataveerat A; Tzong KY; Rasmussen PW; Guzman D; Williams L; Bibbins-Domingo K; Coxson PG; Goldman L
N Engl J Med; 2015 Jan; 372(5):447-55. PubMed ID: 25629742
[TBL] [Abstract][Full Text] [Related]
3. Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?
Grover S; Coupal L; Lowensteyn I
Can J Cardiol; 2008 Dec; 24(12):891-8. PubMed ID: 19052668
[TBL] [Abstract][Full Text] [Related]
4. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
[TBL] [Abstract][Full Text] [Related]
5. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.
Ferket BS; Hunink MG; Khanji M; Agarwal I; Fleischmann KE; Petersen SE
Heart; 2017 Apr; 103(7):483-491. PubMed ID: 28077465
[TBL] [Abstract][Full Text] [Related]
7. How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.
Tang JL; Wang WZ; An JG; Hu YH; Cheng SH; Griffiths S
Int J Epidemiol; 2010 Feb; 39(1):244-54. PubMed ID: 19491141
[TBL] [Abstract][Full Text] [Related]
8. Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
Sheppard JP; Singh S; Fletcher K; McManus RJ; Mant J
BMJ; 2012 Jul; 345():e4535. PubMed ID: 22791787
[TBL] [Abstract][Full Text] [Related]
9. Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
Sheppard JP; Fletcher K; McManus RJ; Mant J
Br J Gen Pract; 2014 Jan; 64(618):e38-46. PubMed ID: 24567581
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
[TBL] [Abstract][Full Text] [Related]
11. Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in primary care: a longitudinal cohort study in the Clinical Practice Research Datalink.
Sheppard JP; Stevens S; Stevens RJ; Mant J; Martin U; Hobbs FDR; McManus RJ
BMJ Open; 2018 Sep; 8(9):e021827. PubMed ID: 30185571
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.
Constanti M; Floyd CN; Glover M; Boffa R; Wierzbicki AS; McManus RJ
Hypertension; 2021 Feb; 77(2):682-691. PubMed ID: 33342242
[TBL] [Abstract][Full Text] [Related]
13. Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis.
Wisløff T; Selmer RM; Halvorsen S; Fretheim A; Norheim OF; Kristiansen IS
BMC Cardiovasc Disord; 2012 Apr; 12():26. PubMed ID: 22475076
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
Schwander B; Gradl B; Zöllner Y; Lindgren P; Diener HC; Lüders S; Schrader J; Villar FA; Greiner W; Jönsson B
Value Health; 2009 Sep; 12(6):857-71. PubMed ID: 19508663
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
[TBL] [Abstract][Full Text] [Related]
17. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.
Vaucher J; Marques-Vidal P; Waeber G; Vollenweider P
Eur J Prev Cardiol; 2018 Jul; 25(10):1111-1113. PubMed ID: 29637794
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and economic impact of the 2017 ACC/AHA guidelines on hypertension in China.
Wang Z; Hao G; Wang X; Chen Z; Zhang L; Zhang Z; Hu H; Weintraub WS; Gao R;
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1212-1220. PubMed ID: 31267666
[TBL] [Abstract][Full Text] [Related]
19. Barriers to management of cardiovascular risk in a low-resource setting using hypertension as an entry point.
Mendis S; Abegunde D; Oladapo O; Celletti F; Nordet P
J Hypertens; 2004 Jan; 22(1):59-64. PubMed ID: 15106795
[TBL] [Abstract][Full Text] [Related]
20. Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK.
Wu R; Rison SCG; Raisi-Estabragh Z; Dostal I; Carvalho C; Robson J; Mihaylova B
BMJ Open; 2021 Dec; 11(12):e052884. PubMed ID: 35536740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
